NUZ 7.50% 18.5¢ neurizon therapeutics limited

Ann: Key Appointment to Progress MPL COVID-19 Clinical Trial, page-56

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 8,978 Posts.
    lightbulb Created with Sketch. 1765
    first off I have to say it wasn't weekly that they were in contact with Syngene, the actual words used were constant communications with Syngene. (Richard Mollard August 2021)
    The fact that they told us three times between December 2020 and June 2021, then the announcement dated 28 July 2021 they announce the delay.
    Which by the way they became aware of in April 2021 (Richard Mollard August 2021) all be it they didn't believe it would affect the time line.
    Now I dont know what you would call it but becoming aware of something in April but not telling shareholders untill 28 July but I call it stringing along.
    Added the next two items to the above,
    The recruitment of dogs in NZ for the continuing of the phrase 2b canine cancer trials was anticipated in December 2021 and now 22 February and nothing reported.
    In the announcement 13 December 2021 states canine Phrase 3 trials to commence in May 2022, however if I look at the timelines shown in the 31 January for canine cancer it shows that the US sites to start First week of February.





 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
18.5¢
Change
-0.015(7.50%)
Mkt cap ! $90.96M
Open High Low Value Volume
20.0¢ 20.5¢ 18.5¢ $106.2K 550.9K

Buyers (Bids)

No. Vol. Price($)
11 714303 18.5¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 26750 1
View Market Depth
Last trade - 16.10pm 18/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.